Nanobiose strengthens ties with MINATEC

Nanobiose is headquartered in Le Bourget du Lac. But since the startup signed an R&D contract with Grenoble Institute of Technology, its staff can often be found at MINATEC using the resources at CIME Nanotech and LMGP.

Founded in July 2016, Nanobiose offers products and services to assess the potential toxicity of nanoparticles, nanodrugs, and biotherapeutics to the human immune system. The company’s non-destructive three-dimensional human cell culture method delivers very accurate results that closely replicate human physiology.
Nanobiose has already applied for one patent and plans to release the first generation of its labs-on-chip on the research market in 2018.

Contact: sarahmilgram@nanobiose.com

Facebook

Twitter